Combat Drugs (India) Financial Diagnostics

COMBDRG -- India Stock  

INR 27.20  0.00  0.00%

Combat Drugs Limited diagnostics interface makes it easy to digest most current publicly released information about Combat Drugs as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Combat Drugs price relationship with some important fundamental indicators such as market cap and management efficiency.

Combat Drugs Note

The company had not issued any dividends in recent years. Combat Drugs Limited had 1:10 split on September 19, 2011. Combat Drugs Limited manufactures and markets pharmaceutical formulations in India. The company was founded in 1986 and is based in Hyderabad, India. Combat Drugs is traded on Bombay Stock Exchange in India. For more info on COMBAT DRUGS please contact the company at 91 40 4853 6100 or go to http://www.combatdrugs.in.

Combat Drugs Limited Alerts

Combat Drugs Limited is not yet fully synchronised with the market data
Combat Drugs Limited generates negative expected return over the last 30 days
Combat Drugs Limited has high likelihood to experience some financial distress in the next 2 years
The company has accumulated 710 K in total debt with debt to equity ratio (D/E) of 3.5 implying the company greatly relies on financing operations through barroing. Combat Drugs Limited has Current Ratio of 0.74 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
COMBAT DRUGS has accumulated about 98 K in cash with (34.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Latest headline from www.cadillacnews.com: Meet Michigans 2018 2nd Congressional District candidates

Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 217.6 M.

Profitablity

The company has Profit Margin (PM) of 5.68 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of 5.72 % which suggests for every 100 dollars of sales it generated a net operating income of 0.06.

Management Efficiency

Combat Drugs Limited has return on total asset (ROA) of 0.01 % which means that it generated profit of $0.01 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 0.03 % meaning that it generated $0.03 on every $100 dollars invested by stockholders.

Combat Drugs Technical and Predictive Indicators

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Equity Analysis

Also Currentnly Active

Purchased over 20 shares of
a day ago
Traded for 107.27
Purchased over 70 shares of
a day ago
Traded for 35.345
Purchased over 20 shares of
a day ago
Traded for 131.79
Check also Trending Equities. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Search macroaxis.com